London, United Kingdom — Plexus Ventures announces the successful completion of a divestment managed on behalf of Labormed, the largest independent pharmaceutical in Romania. The company divested a package of Rx and OTC products to Recordati of Italy.
- Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody
- Celon Pharma enters agreement with Zydus Lifesciences Ltd.
- Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses
- Plexus Ventures’ Important Company Announcement
- Plexus Ventures Assists Valeas S.p.A. to acquire from Pharmactive Biotech Products, SL, Spain licensing and distribution rights for its premium Affron®-based product for commercialization in Italy